Tomas Björklund

Affiliations: 
Brain Repair and Imaging in Neural Systems Lund University, Lund, Skåne län, Sweden 
Area:
Parkinson's Disease, Gene therapy
Website:
http://tomas.wnc.se
Google:
"Tomas Björklund"
Bio:

(Show more)

Mean distance: 17.37 (cluster 11)
 
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Björklund T. (2016) Expression of Multiple Functional RNAs or Proteins from One Viral Vector. Methods in Molecular Biology (Clifton, N.J.). 1382: 41-56
Holmqvist S, Chutna O, Bousset L, et al. (2014) Direct evidence of Parkinson pathology spread from the gastrointestinal tract to the brain in rats. Acta Neuropathologica. 128: 805-20
Aldrin-Kirk P, Davidsson M, Holmqvist S, et al. (2014) Novel AAV-based rat model of forebrain synucleinopathy shows extensive pathologies and progressive loss of cholinergic interneurons. Plos One. 9: e100869
Cederfjäll E, Nilsson N, Sahin G, et al. (2013) Continuous DOPA synthesis from a single AAV: dosing and efficacy in models of Parkinson's disease. Scientific Reports. 3: 2157
Hansen C, Björklund T, Petit GH, et al. (2013) A novel α-synuclein-GFP mouse model displays progressive motor impairment, olfactory dysfunction and accumulation of α-synuclein-GFP. Neurobiology of Disease. 56: 145-55
Ulusoy A, Björklund T, Buck K, et al. (2012) Dysregulated dopamine storage increases the vulnerability to α-synuclein in nigral neurons. Neurobiology of Disease. 47: 367-77
Cederfjäll E, Sahin G, Kirik D, et al. (2012) Design of a single AAV vector for coexpression of TH and GCH1 to establish continuous DOPA synthesis in a rat model of Parkinson's disease. Molecular Therapy : the Journal of the American Society of Gene Therapy. 20: 1315-26
Björklund A, Björklund T. (2011) Gene therapy for Parkinson's disease shows promise. Science Translational Medicine. 3: 79ed1
Hult S, Soylu R, Björklund T, et al. (2011) Mutant huntingtin causes metabolic imbalance by disruption of hypothalamic neurocircuits. Cell Metabolism. 13: 428-39
Björklund T, Cederfjäll EA, Kirik D. (2010) Gene therapy for dopamine replacement. Progress in Brain Research. 184: 221-35
See more...